Stay updated with breaking news from Stephenr davis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA announced it will review a resubmitted supplemental new drug application for Nuplazid for the treatment of hallucinations and delusions associated with Alzheimer’s disease psychosis. Nuplazid (pimavanserin, Acadia Pharmaceuticals) is a selective serotonin inverse agonist and antagonist that targets 5-HT2A receptors, which are thought to play an important role in neuropsychiatric ....